Procter & Gamble Co. Form 10-Q Summary
Business Context and Reporting Period
P&G is a global branded consumer packaged goods company selling in more than 180 countries and territories across Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. This unaudited Form 10-Q covers the three and six months ended December 31, 2021, the second quarter and first half of fiscal 2022, compared with the corresponding periods ended December 31, 2020.
Key Financial Metrics
| Metric | Three Months 2021 | Three Months 2020 | Six Months 2021 | Six Months 2020 |
|---|---|---|---|---|
| Net sales | $20.953 billion | $19.745 billion | $41.291 billion | $39.063 billion |
| Operating income | $5.168 billion | $5.380 billion | $10.191 billion | $10.661 billion |
| Net earnings | $4.242 billion | $3.887 billion | $8.368 billion | $8.195 billion |
| Net earnings attributable to P&G | $4.223 billion | $3.854 billion | $8.335 billion | $8.131 billion |
| Diluted EPS | $1.66 | $1.47 | $3.27 | $3.10 |
| Operating margin | 24.7% | 27.2% | 24.7% | 27.3% |
| Gross margin | 49.1% | 53.1% | 49.1% | 52.9% |
For the six months, operating cash flow was $9.764 billion, capital expenditures were $1.717 billion, adjusted free cash flow was $8.272 billion, and adjusted free cash flow productivity was 99%. Dividends paid were $4.353 billion and share repurchases were $7.504 billion.
At December 31, 2021, cash and cash equivalents were $11.544 billion. Current assets were $25.545 billion versus current liabilities of $38.027 billion, resulting in negative working capital of approximately $12.5 billion. Debt due within one year was $13.331 billion and long-term debt was $22.322 billion. The filing states that long-term debt had a fair value of $28.3 billion, including the current portion of long-term debt instruments.
Material Changes Versus the Prior Comparable Period
- Six-month net sales increased 6%, supported by a 2% increase in unit volume, 2% pricing, 1% favorable mix, and 1% favorable foreign exchange. Organic sales increased 5%.
- Quarterly net sales increased 6%, driven by 3% unit volume growth and 3% pricing; foreign exchange had no net impact.
- Operating income declined 4% for both the quarter and six-month period as commodity, transportation, and mix pressures reduced gross margin despite pricing and productivity savings.
- Six-month net earnings increased 2% and diluted EPS increased 5%, aided by lower interest expense, lower taxes, the prior-year loss on early debt extinguishment, and fewer weighted-average shares.
- Six-month gross margin declined 380 basis points to 49.1%; management attributed the decline primarily to higher commodity costs and unfavorable product mix. SG&A as a percentage of sales improved 120 basis points to 24.4%.
- Fabric & Home Care and Baby, Feminine & Family Care experienced the largest earnings declines: 10% and 15%, respectively, for the six months, despite sales growth of 6% and 4%.
- Health Care sales increased 8% for the six months, with Personal Health Care growth benefiting from respiratory-product demand. Grooming earnings increased 11%, while Beauty earnings were unchanged.
- Cash from operations declined $399 million year over year, primarily reflecting higher accounts receivable and inventory balances. Inventory increased to $6.673 billion from $5.983 billion at June 30, 2021.
- Financing activities used $6.286 billion of cash, compared with $13.171 billion in the prior-year period, reflecting lower debt repayments but increased share repurchases and dividends.
Guidance, Outlook, Commentary, Risks, and Unusual Items
The filing states that fiscal 2022 direct share repurchases are expected to total $9 billion to $10 billion, excluding purchases under compensation and benefit plans. Repurchases may be financed through operating cash flow and short- and long-term debt.
Management expects to fund short-term liquidity and operating needs primarily through operating cash flow and believes its strong credit ratings and access to commercial paper and bond markets will support refinancing needs. The company also maintains access to credit from a diverse group of financial institutions.
- Commodity, transportation, labor, energy, supply-chain, and freight costs remain significant margin risks. Pricing actions may offset costs but could reduce consumer consumption.
- COVID-19 and emerging variants continue to create uncertainty around demand, consumer mobility, supply availability, manufacturing, transportation, and potential pantry destocking.
- Foreign exchange volatility, geopolitical conditions, trade policies, tax-law changes, and regulatory developments may affect sales, margins, earnings, and cash flow.
- The company completed its annual impairment testing and recorded no impairment. The Gillette indefinite-lived intangible asset remains particularly sensitive; its fair value exceeded carrying value by approximately 5% at December 31, 2021. A 25-basis-point increase in the discount rate or decrease in growth rates could reduce its estimated fair value by approximately 6%, and a 50-basis-point decrease in the royalty rate could reduce it by approximately 3%.
- The six-month period included a $512 million pretax loss on early extinguishment of debt in the prior-year period, a current-period gain on the divestiture of minor brands, and changes in retirement-plan benefits and equity-investment results.
- Management believes pending litigation, environmental matters, and currently identified tax uncertainties will not materially affect financial position, results of operations, or cash flows, although ultimate outcomes remain uncertain.
- The filing text states that disclosure controls and procedures were effective and that no material changes occurred in internal control over financial reporting.
Important Facts for Investors to Verify
- Whether pricing can offset commodity and transportation inflation without causing sustained volume declines.
- The sustainability of 99% adjusted free cash flow productivity while inventories, dividends, and share repurchases remain elevated.
- The level and maturity profile of short-term debt, including the $13.331 billion due within one year.
- Progress toward the announced $9 billion to $10 billion fiscal 2022 share-repurchase target and its effect on leverage and diluted EPS.
- Future performance of Fabric & Home Care and Baby, Feminine & Family Care, where earnings declined materially despite sales growth.
- Exposure to COVID-19-related supply disruptions, foreign exchange movements, geopolitical developments, and potential Gillette impairment.
- The effects of non-GAAP adjustments, particularly the prior-year debt-extinguishment charge, when comparing reported EPS with Core EPS.